No longer trading

Acquired by Sanofi

The acquisition closed on February 10, 2026 (SEC 8-K 2.01). Its last closing price was on February 9, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from July 1, 2026. Source: SEC 8-K 2.01

DVAX

DYNAVAX TECHNOLOGIES CORP DVAX

NasdaqSmall CapHealthcare

Final 13F Pro quality score

Final rank #1,668 of 2,856 · as of July 1, 2026

Why it scores 47Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$94.88M

Quarter to Sep 30

Net income

$26.93M

Quarter to Sep 30

Free cash flow

$32.59M

Quarter to Sep 30

Operating margin

22.4%

Quarter to Sep 30

Top Institutional Holders

as of Q1 2026
$93 total
IFP Advisors, Inc
$930.0%
See all 1 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q3 2025
EDGAR

Net Income

Q3 2025
EDGAR

EPS (Diluted)

Q3 2025
EDGAR

Operating Margin

Q3 2025
EDGAR

ROIC

Q3 2025
EDGAR

Free Cash Flow

Q3 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/DVAX

Earnings Per Share

13fpro.ai/company/DVAX

Loading ratio trend…

DVAX key financials by period

Reported revenue, net income and operating margin by fiscal year, from DYNAVAX TECHNOLOGIES CORP's annual filings on SEC EDGAR.

DYNAVAX TECHNOLOGIES CORP reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2024$277.2M$27.3M-1.5%
FY 2023$232.3M$-6.4M-15.9%
FY 2022$722.7M$293.2M39.2%
FY 2021$439.4M$76.7M30.6%
FY 2020$46.6M$-75.2M-146.9%
FY 2019$35.2M$-152.6M—
Source: DVAX filings on SEC EDGAR →

DVAX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About DYNAVAX TECHNOLOGIES CORP (DVAX): stock profile, AI score and financials

Acquired by Sanofi: DYNAVAX TECHNOLOGIES CORP (DVAX) no longer trades and has left 13F Pro's AI-ranked universe. The acquisition closed on February 10, 2026 (SEC 8-K 2.01). Its last closing price was on February 9, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from July 1, 2026. DYNAVAX TECHNOLOGIES CORP (DVAX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro tracks DVAX using direct SEC EDGAR data and AI-powered research tools. Based on the latest XBRL financial filings (Q3 2025), DYNAVAX TECHNOLOGIES CORP reports quarterly revenue of $94.9M, net income of $26.9M, an operating margin of 22.4%. DVAX trades on the Nasdaq exchange and files with the SEC under CIK 1029142. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DVAX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DYNAVAX TECHNOLOGIES CORP directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1029142 →